Anavex Life Sciences Announces Participation at Upcoming World EPA – Evidence, Pricing and Access – Congress 2021

Anavex Life Sciences Announces Participation at Upcoming World EPA – Evidence, Pricing and Access – Congress 2021   NEW YORK – April 7, 2021 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease,…